128 related articles for article (PubMed ID: 28846206)
21. The multifaceted roles of perlecan in fibrosis.
Lord MS; Tang F; Rnjak-Kovacina J; Smith JGW; Melrose J; Whitelock JM
Matrix Biol; 2018 Aug; 68-69():150-166. PubMed ID: 29475023
[TBL] [Abstract][Full Text] [Related]
22. Soluble perlecan domain I enhances vascular endothelial growth factor-165 activity and receptor phosphorylation in human bone marrow endothelial cells.
Muthusamy A; Cooper CR; Gomes RR
BMC Biochem; 2010 Nov; 11():43. PubMed ID: 21047416
[TBL] [Abstract][Full Text] [Related]
23. Biomimetic silk biomaterials: Perlecan-functionalized silk fibroin for use in blood-contacting devices.
Lau K; Waterhouse A; Akhavan B; Gao L; Kim HN; Tang F; Whitelock JM; Bilek MM; Lord MS; Rnjak-Kovacina J
Acta Biomater; 2021 Sep; 132():162-175. PubMed ID: 33588126
[TBL] [Abstract][Full Text] [Related]
24. Localization of glycosaminoglycan substitution sites on domain V of mouse perlecan.
Tapanadechopone P; Hassell JR; Rigatti B; Couchman JR
Biochem Biophys Res Commun; 1999 Nov; 265(3):680-90. PubMed ID: 10600481
[TBL] [Abstract][Full Text] [Related]
25. A current view of perlecan in physiology and pathology: A mosaic of functions.
Gubbiotti MA; Neill T; Iozzo RV
Matrix Biol; 2017 Jan; 57-58():285-298. PubMed ID: 27613501
[TBL] [Abstract][Full Text] [Related]
26. Perlecan domain 1 recombinant proteoglycan augments BMP-2 activity and osteogenesis.
Decarlo AA; Belousova M; Ellis AL; Petersen D; Grenett H; Hardigan P; O'Grady R; Lord M; Whitelock JM
BMC Biotechnol; 2012 Sep; 12():60. PubMed ID: 22967000
[TBL] [Abstract][Full Text] [Related]
27. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells.
Vischer P; Feitsma K; Schön P; Völker W
Eur J Cell Biol; 1997 Aug; 73(4):332-43. PubMed ID: 9270876
[TBL] [Abstract][Full Text] [Related]
28. Perlecan inhibits smooth muscle cell adhesion to fibronectin: role of heparan sulfate.
Lundmark K; Tran PK; Kinsella MG; Clowes AW; Wight TN; Hedin U
J Cell Physiol; 2001 Jul; 188(1):67-74. PubMed ID: 11382923
[TBL] [Abstract][Full Text] [Related]
29. The role of heparan sulfate and perlecan in bone-regenerative procedures.
DeCarlo AA; Whitelock JM
J Dent Res; 2006 Feb; 85(2):122-32. PubMed ID: 16434729
[TBL] [Abstract][Full Text] [Related]
30. A novel peptide sequence in perlecan domain IV supports cell adhesion, spreading and FAK activation.
Farach-Carson MC; Brown AJ; Lynam M; Safran JB; Carson DD
Matrix Biol; 2008 Mar; 27(2):150-60. PubMed ID: 17997086
[TBL] [Abstract][Full Text] [Related]
31. Matrilysin/matrix metalloproteinase-7(MMP7) cleavage of perlecan/HSPG2 creates a molecular switch to alter prostate cancer cell behavior.
Grindel BJ; Martinez JR; Pennington CL; Muldoon M; Stave J; Chung LW; Farach-Carson MC
Matrix Biol; 2014 Jun; 36():64-76. PubMed ID: 24833109
[TBL] [Abstract][Full Text] [Related]
32. Diverse cell signaling events modulated by perlecan.
Whitelock JM; Melrose J; Iozzo RV
Biochemistry; 2008 Oct; 47(43):11174-83. PubMed ID: 18826258
[TBL] [Abstract][Full Text] [Related]
33. Expression of the basement membrane heparan sulfate proteoglycan (perlecan) in human synovium and in cultured human synovial cells.
Dodge GR; Boesler EW; Jimenez SA
Lab Invest; 1995 Nov; 73(5):649-57. PubMed ID: 7474938
[TBL] [Abstract][Full Text] [Related]
34. Perlecan domain I promotes fibroblast growth factor 2 delivery in collagen I fibril scaffolds.
Yang WD; Gomes RR; Alicknavitch M; Farach-Carson MC; Carson DD
Tissue Eng; 2005; 11(1-2):76-89. PubMed ID: 15738663
[TBL] [Abstract][Full Text] [Related]
35. Perlecan protein core interacts with extracellular matrix protein 1 (ECM1), a glycoprotein involved in bone formation and angiogenesis.
Mongiat M; Fu J; Oldershaw R; Greenhalgh R; Gown AM; Iozzo RV
J Biol Chem; 2003 May; 278(19):17491-9. PubMed ID: 12604605
[TBL] [Abstract][Full Text] [Related]
36. Flipping the Molecular Switch: Influence of Perlecan and Its Modifiers in the Tumor Microenvironment.
Cruz LA; Tellman TV; Farach-Carson MC
Adv Exp Med Biol; 2020; 1245():133-146. PubMed ID: 32266656
[TBL] [Abstract][Full Text] [Related]
37. Induction of synthesis of a large heparan sulfate proteoglycan, perlecan, by thrombin in cultured human coronary smooth muscle cells.
Yamamoto C; Wakata T; Fujiwara Y; Kaji T
Biochim Biophys Acta; 2005 Feb; 1722(1):92-102. PubMed ID: 15716125
[TBL] [Abstract][Full Text] [Related]
38. Perlecan domain I gradients establish stable biomimetic heparin binding growth factor gradients for cell migration in hydrogels.
Hubka KM; Carson DD; Harrington DA; Farach-Carson MC
Acta Biomater; 2019 Oct; 97():385-398. PubMed ID: 31351252
[TBL] [Abstract][Full Text] [Related]
39. Perlecan, A Multi-Functional, Cell-Instructive, Matrix-Stabilizing Proteoglycan With Roles in Tissue Development Has Relevance to Connective Tissue Repair and Regeneration.
Hayes AJ; Farrugia BL; Biose IJ; Bix GJ; Melrose J
Front Cell Dev Biol; 2022; 10():856261. PubMed ID: 35433700
[TBL] [Abstract][Full Text] [Related]
40. Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease.
Snow AD; Kinsella MG; Parks E; Sekiguchi RT; Miller JD; Kimata K; Wight TN
Arch Biochem Biophys; 1995 Jun; 320(1):84-95. PubMed ID: 7793988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
